Khadka Bikash, Poudel Saroj, Khanal Kishor, Regmi Ashim, Ghimire Anup, Shrestha Sharad, Kc Shirish, Nepal Rohini
Department of Anaesthesiology and Critical Care Nepal Mediciti Lalitpur Nepal.
Department of Clinical Research Doctors on Wheels Kathmandu Nepal.
Clin Case Rep. 2024 Dec 10;12(12):e9693. doi: 10.1002/ccr3.9693. eCollection 2024 Dec.
BRASH syndrome characterized by bradycardia, renal dysfunction, atrioventricular nodal blockade (AVNB), shock, and hyperkalemia presents diagnostic and management challenges due to its complex pathophysiology and varied clinical presentations. We describe a 90-year-old woman with a history of multiple comorbidities who was on beta blockers bisoprolol for heart failure, presented with shock, refractory hyperkalemia along with bradycardia that required intermittent hemodialysis. Initial management involved aggressive hyperkalemia medical therapy and fluid resuscitation, with subsequent consideration of renal replacement therapy hemodialysis following collaboration with a multidisciplinary team, including cardiology and nephrology specialists. Despite aggressive medical management for hyperkalemia, some cases of BRASH syndrome may remain challenging to treat, requiring intermittent hemodialysis highlighting the need for further research and understanding of this complex clinical entity to improve treatment outcomes.
BRASH综合征的特征为心动过缓、肾功能不全、房室传导阻滞(AVNB)、休克和高钾血症,由于其复杂的病理生理机制和多样的临床表现,在诊断和治疗方面存在挑战。我们描述了一名90岁的女性,有多种合并症病史,因心力衰竭正在服用β受体阻滞剂比索洛尔,出现休克、难治性高钾血症以及需要间歇性血液透析的心动过缓。初始治疗包括积极的高钾血症药物治疗和液体复苏,随后在与包括心脏病学和肾脏病学专家在内的多学科团队协作后,考虑进行肾脏替代治疗——血液透析。尽管对高钾血症进行了积极的药物治疗,但一些BRASH综合征病例的治疗可能仍然具有挑战性,需要间歇性血液透析,这凸显了进一步研究和了解这种复杂临床实体以改善治疗效果的必要性。